Check out the companies making headlines before the bell:Biogen (BIIB) – Biogen soared 45.6% in premarket trading after Biogen and Japanese partner Eisai said their experimental Alzheimer's drug dramatically slowed the disease's progression...
Check out the companies making headlines before the bell:Biogen (BIIB) – Biogen fell 1% in premarket trading after the government announced that Medicare will limit coverage for Aduhelm, Biogen's Alzheimer's disease treatment. Coverage...
